Ofloxacin for Typhoid Fever: Role in Enteric Fever Treatment
Ofloxacin (a fluoroquinolone) is an effective alternative for treating uncomplicated typhoid fever (Salmonella Typhi) and paratyphoid fever (S. Paratyphi A/B/C), particularly in regions with multidrug resistance (MDR) to first-line agents (ampicillin, chloramphenicol, TMP-SMX).
Current WHO/CDC Guidance
- First-line: Ceftriaxone (IV/IM) or azithromycin (oral).
- Fluoroquinolones (ciprofloxacin, ofloxacin): Used when susceptibility confirmed; resistance rising (especially in South Asia). Not for children/pregnancy unless benefits outweigh risks (cartilage toxicity).
Dosing (Adults)
Ofloxacin 400 mg PO/IV q12h × 7–10 days (typhoid); 5–7 days (paratyphoid).
Key Considerations
- Culture & susceptibility essential before fluoroquinolone use.
- Monitor for tendinopathy, QT prolongation, CNS effects, dysglycemia.
- Resistance: gyrA/parC mutations reduce efficacy; nalidixic acid resistance predicts fluoroquinolone treatment failure.
Always follow local antibiogram and infectious disease guidance.
Prescription Medications - Related Articles
- Medication Administration: Why Consistency Matters for Patient Safety
- Medical Abortion After 15 Weeks: Unsafe – Surgical Options Required
- Birth Control Pills and Yeast Infections: Hormonal Link and Prevention
- Deca-Durabolin vs. Equipoise: Understanding Anabolic Steroids
- Understanding Antiviral Drugs: How They Work and Their Role in Treatment
- Ibuprofen & Excedrin Together: Risks, Interactions & Safety
- Darvocet Identification: Recognizing Prescription Painkillers
